Sinsin Pharmaceutical Co. Ltd Asset Resilience Ratio
Sinsin Pharmaceutical Co. Ltd asset resilience ratio. Sinsin Pharmaceutical Co. Ltd (002800) has an Asset Resilience Ratio of 0.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Sinsin Pharmaceutical Co. Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sinsin Pharmaceutical Co. Ltd (2016–2024)
Asset resilience ratio of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. This chart shows how Sinsin Pharmaceutical Co. Ltd's Asset Resilience Ratio has changed over time. Read 002800 total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sinsin Pharmaceutical Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 002800 total asset value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩958.68 Million | 0.73% |
| Short-term Investments | ₩0.00 | 0% |
| Total Liquid Assets | ₩958.68 Million | 0.73% |
Asset Resilience Insights
- Limited Liquidity: Sinsin Pharmaceutical Co. Ltd maintains only 0.73% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Sinsin Pharmaceutical Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Sinsin Pharmaceutical Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 1.48% |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329 |
Drug Manufacturers - Specialty & Generic | 5.92% |
|
Walvax BioTech
SHE:300142 |
Drug Manufacturers - Specialty & Generic | 2.20% |
|
Curaleaf Holdings Inc.
TO:CURA |
Drug Manufacturers - Specialty & Generic | 3.73% |
|
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026 |
Drug Manufacturers - Specialty & Generic | -0.89% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 18.70% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
Sinsin Pharmaceutical Co. Ltd Asset Resilience Ratio by Year (2016–2024)
Sinsin Pharmaceutical Co. Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Sinsin Pharmaceutical Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.42% | ₩539.85 Million ≈ $365.85K |
₩129.48 Billion ≈ $87.75 Million |
+0.14pp |
| 2023-12-31 | 0.28% | ₩346.46 Million ≈ $234.79K |
₩124.41 Billion ≈ $84.31 Million |
-1.57pp |
| 2022-12-31 | 1.85% | ₩2.24 Billion ≈ $1.52 Million |
₩121.21 Billion ≈ $82.14 Million |
+1.15pp |
| 2021-12-31 | 0.70% | ₩799.33 Million ≈ $541.70K |
₩114.31 Billion ≈ $77.46 Million |
-1.42pp |
| 2020-12-31 | 2.12% | ₩2.50 Billion ≈ $1.70 Million |
₩118.13 Billion ≈ $80.06 Million |
+1.03pp |
| 2019-12-31 | 1.09% | ₩1.41 Billion ≈ $955.48K |
₩129.24 Billion ≈ $87.58 Million |
-0.92pp |
| 2018-12-31 | 2.01% | ₩2.17 Billion ≈ $1.47 Million |
₩107.92 Billion ≈ $73.14 Million |
-7.58pp |
| 2017-12-31 | 9.59% | ₩7.56 Billion ≈ $5.12 Million |
₩78.85 Billion ≈ $53.44 Million |
+9.18pp |
| 2016-12-31 | 0.41% | ₩280.00 Million ≈ $189.75K |
₩68.81 Billion ≈ $46.63 Million |
-- |
About Sinsin Pharmaceutical Co. Ltd
Sinsin Pharmaceutical Co., Ltd manufactures and sells pharmaceutical products in South Korea. It offers various medicinal products, such as plaster, aerosol, topical liquid, emollient, hygiene, and ointment products, as well as adhesive bandages, mosquito repellents, anti-perspirants, cooling sheets, bruise treatment creams, and other products. The company also develops transdermal drug delivery … Read more